Compared with the non-NAFLD group, participants in the NAFLD group had a higher BMI, higher frequency of smoking or drinking, higher mean systolic and diastolic BP, shorter diabetes duration, less favorable metabolic profile (FBG, UA, AST, ALT, GGT, TC, and TG), lower HDL-C level and AST/ALT ratio, and higher TyG index (Table 1). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.